Literature DB >> 28407289

Dual Role of the Extracellular Domain of Human Mucin MUC1 in Metastasis.

M S Syrkina1,2, A A Maslakova3, D M Potashnikova4, V P Veiko5, Y S Vassetzky2,6,7,8, M A Rubtsov1,2,9.   

Abstract

Human mucin MUC1 plays an important role in cancer development. The increased level of this molecule expression during cancer cell progression induces metastasis and is associated with poor prognosis for patients. There is a large body of experimental data on the role of various functional domains of human mucin MUC1 in metastasis. While, the cytoplasmic domain determined to play a definitive role, the influence of extracellular domain on cancer cell invasiveness still remains unclear. The present paper reveals that the extracellular domain of MUC1 molecule consists of two functional subdomains-the region of tandem repeats (TR) and the region of irregular repeats (IR). We demonstrate the ability of each of these subdomains to alter the invasiveness of cancer cells. The presence of the MUC1 molecules containing TR subdomain (MUC1-TR) on the surface of low-invasive cancer cells leads to the increase in their transendothelial migration potency, while the addition of the IR subdomain to the MUC1-TR molecule (MUC1-IR-TR) restores their natural low invasiveness. J. Cell. Biochem. 118: 4002-4011, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  CANCER; METASTASIS; MUC1; TRANSENDOTHELIAL MIGRATION; VNTR; sLea

Mesh:

Substances:

Year:  2017        PMID: 28407289     DOI: 10.1002/jcb.26056

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  4 in total

1.  Glycosylated modification of MUC1 maybe a new target to promote drug sensitivity and efficacy for breast cancer chemotherapy.

Authors:  Xiaomin Xi; Jiting Wang; Yue Qin; Weidong Huang; Yilin You; Jicheng Zhan
Journal:  Cell Death Dis       Date:  2022-08-16       Impact factor: 9.685

Review 2.  Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.

Authors:  Divya Thomas; Ashok Kumar Rathinavel; Prakash Radhakrishnan
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-11-04       Impact factor: 10.680

Review 3.  MUC1: Structure, Function, and Clinic Application in Epithelial Cancers.

Authors:  Wenqing Chen; Zhu Zhang; Shiqing Zhang; Peili Zhu; Joshua Ka-Shun Ko; Ken Kin-Lam Yung
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

Review 4.  MUC1 is an oncoprotein with a significant role in apoptosis (Review).

Authors:  Katarzyna Supruniuk; Iwona Radziejewska
Journal:  Int J Oncol       Date:  2021-07-19       Impact factor: 5.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.